An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institute of Standards and Technology and the National Institutes of Health)
A team of researchers from the National Institute of Standards and Technology, the National Institutes of Health, and the University of Maryland have devised a novel, highly sensitive system to track the activity of Cdk5, an enzyme implicated in Alzheimer's disease. The high sensitivity, increased resolution, and fast turnaround time of the measurements can enable a new class of tests that could allow early detection of neurological conditions like Alzheimer’s disease years before the first symptoms appear.
